Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06126705
Status:
RECRUITING
Last Update Posted:
2023-11-13
First Post:
2023-10-30
Brief Title:
18F-AlF-FAPi-04 PETCT Imaging in Patients With Solid Tumor
Sponsor:
Affiliated Hospital of North Sichuan Medical College
Organization:
Affiliated Hospital of North Sichuan Medical College
Study Overview
Official Title:
18F-AlF-FAPi-04 PETCT Imaging in Patients With Solid Tumor
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the potential usefulness of 18F-AlF-FAPi-04 PETCT for the diagnosis of primary and metastatic lesions in solid cancer
Detailed Description:
This is a prospective single-center two arms open label non-randomized study to evaluate the ability of 18F-AlF-FAPi-04 to detect FAP expressing cells in patients with solid tumor evaluate its biological distribution characteristics impact on clinical treatment plans and evaluate imaging differences between different probes Taking histopathology and imaging follow-up as gold standard the sensitivity specificity and accuracy of 18F-AlF-FAPi-04 PETCT will be calculated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None